US EditionPublished • loading... • Updated
Nationwide Recall: FDA Warns Mold in Nasal Spray Could Lead to Life-Threatening Illness
One lot of ReBoost Nasal Spray containing yeast, mold, and Achromobacter bacteria poses risk of life-threatening infections for immunocompromised users, FDA said.
- On Wednesday, the U.S. Food and Drug Administration announced a nationwide recall of one ReBoost Nasal Spray lot after testing found yeast, mold, and Achromobacter, warning of risks to immunocompromised individuals.
- Following internal testing, MediNatura New Mexico, Inc. voluntarily recalled one lot after laboratory test results identified yeast, mold and Achromobacter above specifications.
- The recalled bottles are labeled as 0.68 fl oz , lot 224268, with expiration December 2027, NDC 62795-4005-9, UPC 787647 10186 3.
- Consumers who purchased ReBoost should immediately discontinue use and contact recall@medinatura.com or call 800-621-7644 for refunds, as advised by MediNatura and the FDA.
- Following a separate retail recall, the ReBoost Nasal Spray, marketed for nasal relief, was announced by MediNatura New Mexico Inc., with over 40,000 bottles recalled, reported from Los Angeles.
Insights by Ground AI
17 Articles
17 Articles
Coverage Details
Total News Sources17
Leaning Left1Leaning Right0Center14Last UpdatedBias Distribution93% Center
Bias Distribution
- 93% of the sources are Center
93% Center
C 93%
Factuality
To view factuality data please Upgrade to Premium
